These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15349010)

  • 41. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.
    Mason BJ; Light JM; Williams LD; Drobes DJ
    Addict Biol; 2009 Jan; 14(1):73-83. PubMed ID: 18855801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.
    Glick ID; Marder SR
    J Clin Psychiatry; 2005 May; 66(5):638-41. PubMed ID: 15889952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
    Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence.
    Stedman M; Pettinati HM; Brown ES; Kotz M; Calabrese JR; Raines S
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1822-31. PubMed ID: 20626727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine for insomnia: A review of the literature.
    Anderson SL; Vande Griend JP
    Am J Health Syst Pharm; 2014 Mar; 71(5):394-402. PubMed ID: 24534594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study.
    Bauer M; Pretorius HW; Constant EL; Earley WR; Szamosi J; Brecher M
    J Clin Psychiatry; 2009 Apr; 70(4):540-9. PubMed ID: 19358791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of aripiprazole in alcohol dependence.
    Martinotti G; Di Nicola M; Janiri L
    Am J Drug Alcohol Abuse; 2007; 33(3):393-401. PubMed ID: 17613966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.
    Harvey PD; Hassman H; Mao L; Gharabawi GM; Mahmoud RA; Engelhart LM
    J Clin Psychiatry; 2007 Aug; 68(8):1186-94. PubMed ID: 17854242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment and treatment of insomnia in adult patients with alcohol use disorders.
    Brower KJ
    Alcohol; 2015 Jun; 49(4):417-27. PubMed ID: 25957855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels.
    Montgomery SA; Altamura AC; Katila H; Datto C; Szamosi J; Eriksson H
    Int Clin Psychopharmacol; 2014 Mar; 29(2):93-105. PubMed ID: 24162081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quetiapine may reduce hospital admission rates in patients with mental health problems and alcohol addiction.
    Kong C; Chiu W; Davies A; Keating J
    BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23925678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical experience with quetiapine in elderly patients with psychotic disorders.
    Madhusoodanan S; Brenner R; Alcantra A
    J Geriatr Psychiatry Neurol; 2000; 13(1):28-32. PubMed ID: 10753004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
    McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
    J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of quetiapine in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2002; 63 Suppl 13():27-31. PubMed ID: 12562144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
    Bauer M; McIntyre RS; Szamosi J; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.